VIENNA, Va. (AP) _ Cel-Sci Corp. (CVM) on Wednesday reported a loss of $12.1 million in its fiscal third quarter.
The Vienna, Virginia-based company said it had a loss of 37 cents per share.
The cancer immunotherapy company posted revenue of $108,900 in the period. Its adjusted revenue was $109,000.
Cel-Sci shares have nearly tripled since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $8.44, rising eightfold in the last 12 months.